Alprazolam 2 Mg Oral Tablets (Immediate-Release) 0.25 mg, 0.5 mg, 1 mg, 2 mg Suppliers & Bulk Manufacturers
Available Forms: Oral tablets (immediate-release)
Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg
Reference Brands: Xanax®(US & EU), Niravam®, Alprazolam Intensol®
Category: Antipsychotropic Drugs
Alprazolam enhances GABA activity by binding to benzodiazepine receptors, producing anxiolytic, sedative, and muscle-relaxant effects. It is primarily used for treating anxiety disorders, panic disorders, and short-term relief of anxiety symptoms. Its fast onset makes it effective for acute anxiety episodes and panic attacks.
Product Description:
Alprazolam immediate-release tablets are FDA-approved in the USA for managing anxiety disorders and short-term relief of anxiety symptoms. They are also used in treating panic disorders, often as part of a broader therapeutic plan. Classified as a Schedule IV controlled substance, Alprazolam is subject to prescription-only access due to its dependence risk. In the EU, it is approved under national procedures with similar indications, governed by stringent pharmacovigilance and controlled substance regulations. Regulatory oversight ensures appropriate prescribing and monitoring. For additional forms, global suppliers, and sourcing solutions, explore Pharmatradz.com, your partner in pharmaceutical B2B procurement.
Alprazolam 2 Mg Oral Tablets (Immediate-Release) — third party manufacturing & bulk supply
Alprazolam 2 Mg Oral Tablets (Immediate-Release) 0.25 mg, 0.5 mg, 1 mg, 2 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Alprazolam 2 Mg Oral Tablets (Immediate-Release) is supplied as Oral tablets (immediate-release) — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Alprazolam 2 Mg Oral Tablets (Immediate-Release) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Alprazolam 2 Mg Oral Tablets (Immediate-... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Alprazolam is used for the management of anxiety disorders, panic disorders, and anxiety associated with depression. It helps reduce symptoms such as excessive worry, restlessness, irritability, and panic attacks.
Alprazolam is a synthetic benzodiazepine compound that works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that slows down brain activity and produces a calming effect.
Common trade names include Xanax (widely known global brand), Niravam (orally disintegrating tablets), Alprax (India), Restyl (India), and Alzolam.
Alprazolam was originally developed and marketed by Pfizer under the brand Xanax. It is now manufactured by multiple pharmaceutical companies worldwide, including Teva, Mylan, Sun Pharma, Cipla, and many other generic manufacturers.
The generic name is alprazolam.
Brand names include Xanax, Niravam, Alprax, Restyl, Alzolam, and various other region-specific generics.
Alprazolam is manufactured globally, with major production in the United States, India, Europe, and other regions by both innovator and generic pharmaceutical companies.
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
